Third Rock Ventures
Mark co-founded Third Rock with over 40 years of experience, including more than 30 years launching and building biotechnology companies. Mark focuses on the formation, development and strategic governance of Third Rock's portfolio companies. Mark contributes as an advisor to Third Rock's Fund IV portfolio companies and will continue to play active board roles in the company's current Fund I, II and III portfolio companies.
Mark met Third Rock co-founders Bob Tepper and Kevin Starr while serving as chief executive officer at Millennium Pharmaceuticals, which he co-founded in 1993 and was later acquired by Takeda Oncology.
Third Rock Ventures
2 followers
Third Rock Ventures discovers, launches and builds great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives.